ICONOVO AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8 SEK | +0.50% |
|
0.00% | -30.74% |
| 05-06 | Sweden's Iconovo to Receive Chinese Patent for ICOres Inhaler | MT |
| 05-06 | Iconovo AB Receives Patent Protection for Icores in China | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Companyâs device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
Calendar
2024-07-11
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.74% | 11.66M | |
| +9.48% | 27.45B | |
| -28.65% | 3.11B | |
| -16.08% | 2.55B | |
| +19.05% | 2.48B | |
| +11.11% | 2.08B | |
| -4.24% | 2.03B | |
| +5.56% | 1.55B | |
| +1.69% | 1.29B | |
| +29.73% | 1.23B |
- Stock Market
- Equities
- ICO Stock
- News Iconovo AB
- Iconovo : ISR to Test Inhalable, Nasal COVID-19 Vaccines in Bangladesh